Our innovative end user engaged research programs include:

  • Nanotechnology approaches to target potent cancer therapy directly into breast cancer cells, drastically reducing the damage to healthy cells and enhancing their ability to destroy tumours
  • 3D printing technology for drug targeting
  • Exploring new classes of antimicrobials particularly directed at combating microbial resistance developing nanostructured materials to augment antibiotic treatment
  • Personalised medicine approaches to improving the efficiency of drug dosage regimens and improving efficacy and reducing toxicity of medications
  • Developing implants that protect native fauna populations.

Our research groups